🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine whether Leukotriene A4 hydrolase (LTA...
Status
Completed
Location
Hospital for Tropical Diseases
Start Date
2018-02-12
Trial ID
NCT03100786
Treatments Being Tested
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074
This study will answer two separate questions. The first question is to te...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-05
Trial ID
NCT00879970
Treatments Being Tested
Evaluate the safety and tolerability of sotorasib in adult subjects with KR...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-27
Trial ID
NCT03600883
Treatments Being Tested
The purpose of this study is to determine if non-invasive distracting devic...
Status
Terminated
Location
Stanford University
Start Date
2021-02-01
Trial ID
NCT04376242
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
University of Calgary Liver Unit - Heritage Medical Research Clinic
Start Date
2018-08-28
Trial ID
NCT03615066
Treatments Being Tested
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
Dyslipidemia (DL) is a metabolic disorder characterized by an imbalance of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-15
Trial ID
NCT07624604
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of upada...
Status
Completed
Location
East View Medical Research, LLC /ID# 171133
Start Date
2017-11-29
Trial ID
NCT03345836
Treatments Being Tested
First-in-human, single centre, two parts, dose-escalation, parallel-group, ...
Status
Recruiting
Location
CROSS Research S.A. Phase I Unit
Start Date
2024-12-04
Trial ID
NCT06705998
Treatments Being Tested